Tag Archives: patient’s

FDA Approves Tazverik (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma

FDA Approves Tazverik (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Print this page CAMBRIDGE, Mass.–(BUSINESS WIRE)–Jan. 23, 2020– Epizyme, Inc. (Nasdaq: EPZM), a biopharmaceutical company developing novel epigenetic therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Tazverik (tazemetostat) for the treatment of adults and pediatric… Read More »

FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia in Adult Patients

FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia in Adult Patients Print this page December 23, 2019 — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) today announced that the U.S. Food and Drug Administration (FDA) approved the new drug application for its in-house discovered and developed orexin receptor antagonist Dayvigo (lemborexant). Dayvigo… Read More »

Accessing medical records improves patient care, but only 10% of patients do so

Despite the numerous benefits associated with patients accessing their medical records, a study published in Health Affairs found only 10% of patients utilize the resource. Researchers expected to find inequities in use and access — in theory, driven by existing digital disparities, those who don’t use English as a first-language or communities without access to… Read More »